Skip to content
Posted on March 29, 2023 by: eqs

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

PR in the Philippines

Press Releases, Company Events, Business Chances in the Philippines

Posted on March 29, 2023 by: eqs

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

  • Home
  • SEAPRWire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact

Q&A: Australia’s nuclear-powered submarines and ASEAN’s reaction

  • Home
  • Life
  • Q&A: Australia’s nuclear-powered submarines and ASEAN’s reaction
Posted on March 17, 2023
Categories: Life

Post navigation

Japan, South Korea move to mend ties at landmark summit
Fujitsu and Ochanomizu University establish new AI ethics research lab, leveraging AI technologies to promote gender equality

Categories

  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • Life
  • Manila
  • People
  • SEAPRWire

Recent Posts

  • Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China
  • NEC Technology Successfully Predicts High Risk Areas for Presence of Landmines
  • Society Pass’ (Nasdaq: SOPA) Thoughtful Media Group Launches in Vietnam Market, Revolutionizing the Creator Economy with Integrated Marketing Services
  • Paribus Announces Mainnet v1 Launch
  • Pagoda Group Profit Attributable to the Owners of the Company Surges 40.4% in FY2022

Menu

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
Copyright © 2023 PR in the Philippines